New Delhi, May 11 -- justify;">GLP-1 agonists such as tirzepatide and semaglutide have captured public attention for their ability to induce rapid weight loss. Studies suggest these drugs can reduce body weight by up to 22.5% over 72 weeks hence, it is crucial to be aware of potential risks and side effects that may emerge with extended use.

In an interview with HT Lifestyle, Dr Zeeshan Ali, MD, PhD, Nutrition Expert and Research Program Specialist at the Physicians Committee for Responsible Medicine (PCRM), shared, "Gastrointestinal side effects-such as nausea, constipation and abdominal pain-are commonly reported. There is also emerging research indicating potential risks, including gallbladder issues and vision loss which warrants fur...